SCHEMBL12819210

SCHEMBL12819210

Cn1ccc2cc(S(=O)(=O)N3CCOc4ccc(-c5ccc(C#N)s5)cc43)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 3/20 0.38
▸ PKLR P30613 3/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ KDM2B Q8NHM5 1/20 0.36
▸ PDE3B Q13370 3/20 0.35
▸ PDE3A Q14432 3/20 0.35
▸ THRB P10828 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ PGR P06401 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ PPARG P37231 1/20 0.33
▸ PPARD Q03181 1/20 0.33
▸ PPARA Q07869 1/20 0.33
▸ LGMN Q99538 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818531 0.87 PKM (0.45) PKMPKLRCYP2C9PDE3BPDE3A
SCHEMBL12818609 0.86 PKM (0.38) PKMPKLRCYP2C9KDM2BPDE3B
SCHEMBL12818456 0.86 KDM2B (0.37) PKMPKLRCYP2C9KDM2BPDE3B
SCHEMBL12817792 0.85 KMT2A (0.44) PKMPKLRCYP2C9PDE3BPDE3A
SCHEMBL12818115 0.85 NPC1 (0.42) PKMPKLRCYP2C9NPC1MEN1
SCHEMBL1818909 0.84 PKM (0.48) PKMPKLRCYP2C9LMNANPC1
SCHEMBL1818674 0.84 CYP2C9 (0.53) PKMPKLRCYP2C9PDE3BPDE3A
SCHEMBL12818475 0.83 PKM (0.38) PKMPKLRKDM2BTHRBLMNA
SCHEMBL12818264 0.83 PDE3B (0.39) PKMPKLRCYP2C9KDM2BPDE3B
SCHEMBL12818685 0.83 PKM (0.38) PKMPKLRCYP2C9KDM2BPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback